Your browser doesn't support javascript.
loading
Approach to the patient with suspected hypotonic polyuria.
Newell-Price, John; Drummond, Juliana Beaudette; Gurnell, Mark; Levy, Miles; McCormack, Ann; Cooper, Deborah; Wass, John; Christ-Crain, Mirjam; Verbalis, Joseph G.
Affiliation
  • Newell-Price J; School of Medicine and Population Health, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK.
  • Drummond JB; Department of Internal Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, MG - CEP 31270-901, Brazil.
  • Gurnell M; Institute of Metabolic Science & Department of Medicine, University of Cambridge & Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.
  • Levy M; Department of Endocrinology, University Hospitals of Leicester NHS Trust, Leicester, LE3 9QP  UK.
  • McCormack A; Department of Endocrinology, St Vincent's Hospital, Sydney, NSW 2010, Australia, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia, St Vincent's Clinical School, University of New South Wales, Sydney, NSW 2052, Australia.
  • Cooper D; Trustee, The Pituitary Foundation, Brunswick Court, Brunswick Square, St Paul's, Bristol BS2 8PE.
  • Wass J; Department of Endocrinology, University of Oxford, Churchill Hospital, Oxford OX3 7LE, UK.
  • Christ-Crain M; Department of Endocrinology, University hospital and University of Basel, CH-4031 Basel, Switzerland.
  • Verbalis JG; Georgetown-Howard Universities Center for Clinical and Translational Science, Georgetown University, Washington, DC 20007  USA.
Article in En | MEDLINE | ID: mdl-39148427
ABSTRACT
Investigation and management of hypotonic polyura is a common challenge in clinical endocrinology. The three main causes, recently renamed to arginine vasopressin deficiency (AVP-D, formerly central diabetes insipidus), AVP-resistance (AVP-R, formerly nephrogenic diabetes insipidus), and primary polydipsia (PP) require accurate diagnosis as management differs for each. This new nomenclature more accurately reflects pathophysiology, and has now been adopted by the Systemised Nomenclature of Medicine (SNOMED). Advances in diagnosis over the last few years have centered around the use of copeptin measurement. Here, we use three patient case histories to highlight the use of this approach, and to demonstrate how it can succeed where other approaches, such as the water deprivation test, sometimes fail. We discuss the overall approach to each type of patient and the strengths and limitations of diagnostic strategies, illustrating the use of the new nomenclature.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Clin Endocrinol Metab Year: 2024 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Clin Endocrinol Metab Year: 2024 Document type: Article Country of publication: United States